New diabetes clinical trial: Effect of Empagliflozin on Body Composition and Ketones

Published on: March 15, 2019 at 06:00PM
Conditions:   Diabetes Mellitus;   Fat; Intolerance, Pancreas
Interventions:   Drug: Empagliflozin 10 MG;   Drug: Hypoglycemics Oral
Sponsor:   Seoul National University Bundang Hospital
Recruiting